Clinical trials
Completed Coronary Artery Disease trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
160 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 11 |
| 2007 | 7 |
| 2008 | 14 |
| 2009 | 8 |
| 2010 | 17 |
| 2011 | 10 |
| 2012 | 5 |
| 2013 | 14 |
| 2014 | 10 |
| 2015 | 6 |
| 2016 | 2 |
| 2017 | 9 |
| 2018 | 6 |
| 2019 | 10 |
| 2020 | 2 |
| 2021 | 10 |
| 2022 | 6 |
| 2023 | 3 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 160 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seung-Jung Park | 33 |
| Yonsei University | 22 |
| Seoul National University Hospital | 20 |
| Seoul National University Bundang Hospital | 9 |
| Samsung Medical Center | 7 |
| Bayer | 4 |
| AstraZeneca | 3 |
| CardioVascular Research Foundation, Korea | 3 |
| Inje University | 3 |
| Wonju Severance Christian Hospital | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 160 |
| Coronary Disease | 15 |
| Myocardial Ischemia | 10 |
| Acute Coronary Syndrome | 7 |
| Cardiovascular Diseases | 7 |
| Diabetes Mellitus | 7 |
| Peripheral Arterial Disease | 7 |
| Atherosclerosis | 6 |
| Angina, Stable | 5 |
| Angina, Unstable | 5 |
Trials
Showing 1 to 25 of 160. Each trial links to its page on Pharma Observatory.
60 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.